Could Your Long-Term Care Premiums Be Hiding in Plain Sight?
If you have a permanent life insurance policy or annuity, you may be able to trade it for long-term care coverage.
2 Ultrashort Bond Fund Picks for a Rising Rate Environment
Bronze-rated Fidelity Conservative Income and Silver-rated PIMCO Short-Term Institutional offer lower rate sensitivity relative to short or intermediate-term bond funds.
Walmart Thrives Despite Competitive Onslaught
The wide-moat retailer's considerable competitive advantages should continue to translate well into digital retail.
Cisco Impresses, Shares Slightly Rich
The narrow-moat firm's largest advantage may be its ability to sell an entire networking solution whereas competitors can only offer partial solutions.
Investing in a Core Low-Carbon Fund
Carbon-risk metrics reveal dozens of choices.
Premium Exclusive
2 Undervalued Stocks Among Berkshire's Latest Buys
The company added to several positions during the second quarter, and two of those stocks are in buying range today according to our ratings.
Investing Libraries
Morningstar Specialists
How to Escape from a Lousy Health Savings Account
You may be switching to cut costs, but watch out: You may trigger additional fees along the way.
11 Index Funds Offering Almost-Free Broad Market Exposure
Though these index funds and ETFs aren't free from a cost perspective, they are not tethered to one brokerage platform.
How Fund Pricing Has--and Hasn't--Improved
Unbundling fees is a clear improvement, but a couple of problems remain.
How to Blend Work and Retirement
For many, retirement isn't a full stop. Contributor Mark Miller discusses how to plan for a phased retirement that includes work and shares useful resources.
What Fidelity's No-Cost Index Funds Mean for Investors
Fidelity sends a jolt to the asset-management industry.
The Case for Multifactor Funds
Investors are likely best served by not putting all their factor bets in one basket.
Morningstar Videos
Best Investments
5-Star Stocks
Looking for bargains? These companies are all trading below what our analysts think they are worth.
